Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  ICON PLC    ICLR   IE0005711209

ICON PLC

(ICLR)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/19/2019 08/20/2019 08/21/2019 08/22/2019 08/23/2019 Date
157.37(c) 156.72(c) 155.57(c) 156.31(c) 153.41(c) Last
118 833 220 450 208 000 126 577 133 670 Volume
+0.13% -0.41% -0.73% +0.48% -1.86% Change
More quotes
Financials (USD)
Sales 2019 2 812 M
EBIT 2019 431 M
Net income 2019 372 M
Finance 2019 195 M
Yield 2019 -
Sales 2020 3 032 M
EBIT 2020 478 M
Net income 2020 413 M
Finance 2020 456 M
Yield 2020 -
P/E ratio 2019 22,3x
P/E ratio 2020 20,0x
EV / Sales2019 2,88x
EV / Sales2020 2,59x
Capitalization 8 296 M
More Financials
Company
ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that... 
More about the company
Surperformance© ratings of ICON PLC
Trading Rating : Investor Rating :
More Ratings
Latest news on ICON PLC
08/09ICON : Forbes names ICON in list of Best Employers in America for Women
PU
07/24ICON : Reports Second Quarter 2019 Results
BU
07/24ICON : Announces the Appointment of Ms. Julie O'Neill to Board of Directors and ..
BU
07/24ICON : Shareholders Vote in Favour of All Resolutions at its Annual General Meet..
BU
06/24ICON : and DIA Driving Insights to Action with DIA Live 2019
BU
05/23ICON : Acquisition of MeDiNova Research
BU
05/13ICON : Awarded Clinical Research Team of the Year and Best in Health Economics a..
BU
05/09ICON : Launches New Patient Engagement Platform to Support Improved Patient Expe..
BU
05/01ICON : Reports First Quarter 2019 Results
BU
04/25ICON : Forbes names ICON one of the best employers in America
PU
More news
Analyst Recommendations on ICON PLC
More recommendations
Sector news : Biotechnology & Medical Research - NEC
08/22GSK's long acting HIV injection gets boost from study
RE
08/15European Medicines Agency Reviews Arthritis Treatment by Gilead, Galapagos
DJ
08/12REGENERON PHARMACEUTICALS : Two Experimental Ebola Drugs Reduce Mortality Rate
DJ
08/08Sarepta says adverse event report for DMD gene therapy erroneously submitted
RE
08/08AGENUS : FDA Accepts AGEN2373 IND, Triggering $7.5 Million Milestone
DJ
More sector news : Biotechnology & Medical Research - NEC
Chart ICON PLC
Duration : Period :
ICON PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ICON PLC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 165,60  $
Last Close Price 153,41  $
Spread / Highest target 20,6%
Spread / Average Target 7,95%
Spread / Lowest Target -19,8%
EPS Revisions
Managers
NameTitle
Stephen A. Cutler Chief Executive Officer & Executive Director
Ciaran Murray Executive Chairman
Brendan Brennan Chief Financial Officer
Tom O'Leary Chief Information Officer
John Climax Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
ICON PLC18.73%8 296
IQVIA HOLDINGS INC31.83%30 667
LONZA GROUP37.85%26 493
INCYTE CORPORATION28.81%18 401
CELLTRION, INC.--.--%16 093
EXACT SCIENCES CORPORATION86.80%15 262